How AI is shortening drug discovery timelines in China
Insilico Medicine has reduced the time needed to produce some drug development candidates to about one year by combining artificial intelligence with laboratory research in...
Author : Carla M. Dingman
Meta, Microsoft, Nvidia, IBM, and others back open-weight AI
Two dozen companies and organisations signed an open letter urging US policymakers to protect open-weight AI models. The letter, published today (PDF), carries signatures from...
OpenAI pushes ChatGPT into patient health records
OpenAI is deploying a Health feature inside ChatGPT, giving users the option to connect Apple Health data and medical records to the chatbot. Logged-in users...
Nvidia bets physical AI can solve healthcare robotics’ data problem
Nvidia’s new Medical Physics Simulation framework treats healthcare robots as physical AI systems that need embodied experience to learn, not just code. Physical AI is...
Nvidia bets physical AI can solve healthcare robotics’ data problem
Nvidia’s new Medical Physics Simulation framework treats healthcare robots as physical AI systems that need embodied experience to learn, not just code. Physical AI is...
Chinese open-weight models are cheap. Washington is deciding what that costs.
Enterprises evaluating Chinese open-weight models this month face a question that has nothing to do with benchmarks: whether using one will still be straightforward in...
Kimi K3 open-weight model: China’s biggest AI is a bet on memory, not compute
Moonshot AI’s Kimi K3 open-weight model has been read almost entirely through its parameter count since it launchedon July 16. At 2.8 trillion parameters, it is...
Bunkerhill raises $55M to scale agentic AI across health systems
Bunkerhill Health has raised $55 million to scale its agentic AI platform, Carebricks. The closing of the company’s Series B round, announced today, folds in...
How to shrink the token budget without shrinking the team
Jensen Huang has a test for whether an engineer is worth keeping, and it comes with a token budget attached. Speaking on the All-In Podcast...
AWS GraphRAG deployment cuts drug research cycles by 87%
A recent AWS GraphRAG deployment reduced drug research and development cycles in pharmaceutical environments by 87 percent. This acceleration is achieved by integrating previously separated...